The Assessment of the Innovativeness of a New Medicine in Italy
Objectives: Starting from April 2017, the Italian Medicine Agency (AIFA) has approved new criteria for defining any new medicinal product with an innovative indication. The purpose of the study is to analyze the activity of innovativeness evaluation according to the new approach, to estimate the wei...
Main Authors: | Filomena Fortinguerra, Serena Perna, Roberto Marini, Alessandra Dell'Utri, Maurizio Trapanese, Francesco Trotta, Scientific & Technical Committee (Commissione Tecnico-Scientifica, CTS) of Italian Medicines Agency-AIFA |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.793640/full |
Similar Items
-
Alethic deflationism and normativity: a critique = Deflacionismo alético e normatividade: uma crítica
by: Dell'Utri, Massimo
Published: (2018-01-01) -
Reducing criminal recidivism in Alaska: The Set Free Model
by: Ryan Ray, et al.
Published: (2023-09-01) -
Manual for the planning and implementation of therapeutic studies /
by: 437584 Biefang, Sibylle, et al.
Published: (1983) -
Introduction: Ten Trips Around the Conceptual Galaxy of Otherness
by: Massimo Dell’Utri, et al.
Published: (2014-06-01) -
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen
by: Viviana Giannuzzi, et al.
Published: (2017-04-01)